Cancer Research
MOBILE, Ala. — Researchers at the University of South Alabama (USA) College of Medicine have been awarded a $1.15-million U.S. Department of Defense grant to study the effect of nicotine on prostate health, Business Alabama reported. Among other steps, the researchers will compare prostate tumor tissue from patients who smoke to that of patients who…
MOBILE, Ala. — The USA Health MCI has again earned a three-year accreditation from the Commission on Cancer (CoC), which recognizes excellence in the delivery of comprehensive, patient-centered cancer care. The oncology program at USA Health (including MCI since it opened in 2008) has been accredited since 1976. The CoC Accreditation Program provides the framework…
Researchers at the USA Health Mitchell Cancer Institute (MCI) and the University of South Alabama (USA) College of Medicine uncovered a novel mechanism that underlies castration therapy resistance in metastatic prostate cancer. Their findings were published recently in the British Journal of Cancer. Dr. Mohammad Aslam Khan, a senior research associate at MCI, is one…
Dr. Santanu Dasgupta, a cancer researcher at the USA Health Mitchell Cancer Institute (MCI) and assistant professor of pathology at the University of South Alabama (USA) College of Medicine, recently received a $126,000 grant from the Elsa U. Pardee Foundation to identify certain stress-related factors that aid in initiation and progression of cervical cancer. In…
The University of South Alabama (USA) has announced a discovery by scientists at its College of Medicine that may provide further understanding of genes and factors that cause cancers in relation to DNA damage. An article about the discovery was recently published in the scientific journal Cell Reports. “This breakthrough research uses state-of-the-art microscopy and…
Dr. Gary Piazza, professor of pharmacology at the University of South Alabama (USA) College of Medicine and co-lead investigator, is part of a collaboration to explore a potential treatment for aggressive cancers and discovered and developed a novel RAS inhibitor class. RAS inhibitors may help treat aggressive RAS-driven cancers such as pancreatic, colon and lung…
Ready to Subscribe?
Get weekly updates delivered right to your inbox.
